Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04732481
Other study ID # QP-RIPH3-001
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 1, 2021
Est. completion date September 1, 2021

Study information

Verified date March 2022
Source Centre Hospitalier de Cornouaille
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Patients hospitalized in intensive care often require intravenous administration of fluid in order to optimize the functioning of the heart and thus ensure perfusion of vital organs such as the kidneys, the brain or the digestive tract. However, it is necessary to find the right balance in fluid intake because it has been shown that excessive administration has a negative impact on patient survival, the length of their stay in intensive care or the duration of invasive mechanical ventilation.The passive leg lifting maneuver is regularly used to determine which patients should be infused with these large volumes (the patient's chest is placed in a horizontal position and the legs are elevated at 30 ° by tilting the bed for 2 minutes ). To be interpreted, this maneuver requires the presence of invasive devices (bloody arterial pressure catheter, PICCO monitor) or an operator experienced in cardiac ultrasound.Our study aims to evaluate an easy-to-use, non-invasive tool widely available in intensive care and emergency departments (carotid vascular doppler ultrasound) to assess the response to a passive leg lifting maneuver. . The measurements are taken before and after a passive leg lifting maneuver and then before and after a filling decided before inclusion by the doctor responsible for the patient.


Recruitment information / eligibility

Status Completed
Enrollment 21
Est. completion date September 1, 2021
Est. primary completion date June 1, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - equipped with a PICCO2® continuous cardiac output monitoring device - for which the practitioner in charge of the patient decides to administer a volume expansion Exclusion Criteria: - patients whose rhythm is non-sinus - who have expressed their refusal to participate in the protocol - contraindicated to passive leg lifting maneuvers (deep vein thrombosis, HTIC, BMI> 40 or> 14, spinal instability) - pregnant women and patients clinically suspected of abdominal compartment syndrome

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
passive leg lift test
passive leg lift test

Locations

Country Name City State
France Ch Cornouaille Quimper Finistere

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier de Cornouaille

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary response to filling Collection of the diagnosis of response to filling after volume expansion of 500mL of Isotonic Salted Serum and evaluation of the variation in TFCc during passive leg lifting between the two groups 90sec
Secondary cut-off value for positivity of the test The secondary objective of this work is to determine the best positivity threshold value of the test studied as well as its sensitivity and specificity for the chosen value. 90sec
See also
  Status Clinical Trial Phase
Completed NCT02520440 - INtestinal Failure, multiPle Organ Failure ANd CItrulline Assessment N/A
Recruiting NCT04695119 - Sepsis in the ICU-II
Not yet recruiting NCT05872152 - Impact of Fourier Transform Infrared Spectroscopy (FTIRS) in ICUs N/A
Not yet recruiting NCT04502511 - Heterogeneity of Critical Illness: a Cohort Study
Recruiting NCT03825250 - The Val-CARD Trial Phase 1/Phase 2
Completed NCT03344627 - Clinical Outcome Study of High-dose Meropenem in Sepsis and Septic Shock Patients N/A
Completed NCT04772703 - DNA Damage in Critically Ill COVID-19 Patients
Recruiting NCT04015973 - The PRE-OP ENERGY Trial N/A
Withdrawn NCT03933930 - Comparing the Prognosis of Lactate-directed and Goal-directed Therapy in Hyperthermic Intraperitoneal Chemotherapy. N/A
Completed NCT03075605 - PROOF: Pancreatitis-associated Risk Of Organ Failure
Not yet recruiting NCT06330610 - Evaluation of the Efficiency of Intermittent Enteral Nutrition on Multi-organ Failure From Patients With Mechanical Ventilation in Intensive Care Unit N/A
Not yet recruiting NCT03282253 - Elevated Stearoyl-CoA Desaturase-1 Expression Predicts the Disease Severity of Severe Acute Pancreatitis N/A
Completed NCT05972980 - Ventilator-Associated Pneumonia in Critically Ill COVID-19 vs. Non-COVID-19 Patients
Withdrawn NCT03167788 - Red Cell Rejuvenation for the Attenuation of Transfusion Associated Organ Injury in Cardiac Surgery Phase 2
Recruiting NCT05405426 - Trial of Indication-Based Transfusion of Red Blood Cells in ECMO N/A